Distribution of the Cellular Uptake of Phosphorothioate Oligodeoxynucleotides in the Rat Kidney in vivo

Nephron

Volumn 75, Issue 1, 1997, Pages 82-87

  Carome, Michael A ^a   Kang, Yuan Hsu ^b   Bahen, Erin M ^a   Nicholson, Diarmuid E ^a   Carr, Frances E ^a   Kiandoli, Luana C ^a   Brumme, Sara E ^b   Yuan, Christina M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Antisense; Autoradiography; Gene therapy; Phosphorothioate oligonucleotide; Rat kidney

Indexed keywords

OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; GLOMERULUS; HENLE LOOP; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET ORGAN;

EID: 0031017451     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189504     Document Type: Article

References (39)

1. Cohen JS: Oligonucleotides as therapeutic agents. Pharmacol Ther 1991:52:211-225.
2. Dolnick BJ: Antisense agents in pharmacology. Biochem Pharmacol 1990:40:671-675.
3. Helene C, Toulme JJ: Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990:1049:99-125.
4. Stein CA. Cohen JS: Oligodeoxynucleotides as inhibitors of gene expression: A review. Cancer Res 1988:48:2659-2668.
5. Agrawal S, Mayrand SH, Zamccnik PC, Pederson T: Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligonucleotides. Proc Natl Acad Sci USA 1990: 87:1401-1405.
6. Waldcr RY. Walder JA: Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proc Natl Acad Sci USA 1988:85: 5011-5015.
7. Kitajima I, Shinohara T. Bilakovics J, Brown DA. Xu X. Ncrcnberg M: Ablation of transplanted HTLV-1 Tax-transformed tumors in mice by antisense inhibition of NF-kB. Science 1992:258:1792-1795.
8. Ratajezak MZ. Kant JA. Lugcr SM. Hijiya N, Zhang J, Zon G. Gcwirtz AM: In vivo treatment of human leukemia in a scid model with c-myb antisense oligodeoxynucleotides. Proc Nati Acad Sci USA 1992:89:11823-11827.
9. Skorski T. Nieborowska-Skorska M. Nico-laides NC. Szczylik C, Iversen P. lozzo RV. Zon G, Calabretta B: Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 1994;91:4504-4508.
10. Simons M, Edelman ER. DeKcyser JL Langer R. Rosenberg RD: Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature 1992:359: 67-70.
11. Amaralunga A. Morin PJ. Kosik KS, Fine RE: Inhibition of kinesin synthesis and rapid anterograde axonal transport in vivo by an antisense oligonucleotide. J Biol Chem 1993:268: 17427-17430.
12. Agrawal S. Temsamani J. Tang JY: Pharmacokinetics, biodistribution, and stability of oli-godeoxynucleolide phosphorothioates in mice. Proc Natl Acad Sci USA 1991;88:7595-7599.
13. Bigelow JC, Chrin I.R. Mathews LA. McCormack JJ: High-performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluids. J C'hromatogr 1990:533:133-140.
14. Goodchiid J. Kim B. Zamecnik PC: The clearance and degradation ofoligodcoxynucleotides following intravenous injection into rabbits. Ant ¡sense Res Dev 1991; 1:153-160.
15. Gewirtz AM. Calabretta B: A c-myb antisense oligodcoxynucleotidc inhibits normal human hematopoiesis in vitro. Science 1988:242: 1303-1306.
16. Wickstrom EL, Bacon TA. Gonzalez A. Freeman DL. Lyman GH, Wickstrom E: Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression arc inhibited by an antisense pentadecadcoxynueleotide targeted against c-mvcmRNA. Proc Natl Acad Sci USA 1988;85:1028-1032.
17. Sagata N, Oskarsson M, Copeland T. Brumbaugh J. Vande Woude GF: Function of c-mas proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature 1988:335:519-525.
18. Barccllini-Couget S. Pradines-Figueres A. Roux P. Dani C. Ailhaud G: The regulation by growth hormone of lipoprotein lipase gene expression is mediated by c-fos protooncogene. Endocrinology 1993;132:53-60.
19. Manson J, Brown T, Duff G: Modulation of interleukin 1β gene expression using antisense phosphorolhioate oligonucleotides. Lymphokine Res 1990:9:35-42.
20. Harel-Bcllan A. Durum S. Muegge K. Abbas AK. Farrar WL: Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Thl and Th2 helper T cell clones. J Exp Med 1988:168: 2309-2318.
21. Levy Y, Tsapis A, Brouct JC: lnterlcukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J Clin Invest 1991; 88:696-699.
22. Morrison RS: Suppression of basic fibroblast growth factor expression by antisense oligonucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 1991:266:728-734.
23. Kulka M, Smith CC. Levis J. Fishelevich R. Hunter JC. Cushman CD. Miller PS, Tso PO. Aurclian L: Synergistic antiviral activities of oligonucleotide mcthvlphosphonatcs complementary to herpes simplex virus type I immediate-early mRNAs 4. 5. and I. Antimicrob Agents Chemothcr 1994;38:675-680.
24. Zamecnik PC. Stephenson ML: Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodcoxynucleotidc. Proc Natl Acad Sci USA 1978:75:280-284.
25. Kitajima I. Shinohara T. Minor T. Bibbs L. Bilakovics J, Nerenberg M: Human T-ccll leukemia vims type 1 tax transformation is associated with increased uptake of oligodeoxynu-clcotidcs in vitro and in vivo. J Biol Chem 1992;267:25881-25888.
26. Agrawal S. Tang JY: GEM 91-An antisense oligonucleotide phosphorolhioate as a therapeutic agent for AIDS. Antisense Res Dev 1992;2:261-266.
27. Edwards JC. Hamm LL. Hcring-Smith K. Redhead C: Suppression of cAMP-activated anion permeability in T84 cells using antisense oligonucleotide from a novel Cl-channel gene. J Am Soc Nephrol 1992:3:806.
28. Cook JL. Chen L, Bhandaru S. Bakris GL. Re RN: Tltc use of antisense oligonucleotide to establish autocrine angiotensin growth effects in human neuroblastoma and mesangial cells. Antisense Res Dev 1992:2:199-210.
29. Macshima Y. Kashihara N. Sugiyama H. Scki-kawa T. Okamoto K. Kanao K. Morita Y. Yamasaki Y. Makino H. Ola Z: Inhibition of human mesangial cell proliferation by anti-sense oligonucleotides targeting proliferating cell nuclear antigen and Ki-67 mRNA. J Am Soc Nephrol 1994:5:786.
30. Rothenspieler UW. Dressier GR: Mesenchyme to epithelium conversion inhibited by anti-sense oligonucleotide directed against Pax-2. J Am Soc Nephrol 1992:3:477.
31. Rothenspieler UW: Antisense oligodeoxynu-clcotides directed against Wilms' Tumor gene WTI inhibit kidney differentiation and development. J Am Soc Nephrol 1994:5:635.
32. Wada J. Liu ZZ. Alvares K. Kumar A. Wallner E. Makino H, Kamvar YS: Cloning of cDNA for the a subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development. Proc Natl Acad Sci USA 1993:90:10360-10364.
33. Sariola H. Saarma M. Sainio K. Arumac U, Palgi J. Vaahtokari A, Thesleff I, Karavanov A: Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 1991:254:571-573.
34. Phillips ML Wielbo D. Gyurko R: Antisense inhibition of hypertension: A new strategy for renin-angiotensin candidate genes. Kidney Ini 1994;46:1554-1556.
35. Rappaport J. Hanss BG, Kopp JB, Copeland TD. Bruggeman LA. Coffman TM. Klotman PE: Transport of phosphorolhioate oligonucleotides in kidney: Implications for molecular therapy. Kidney Int 1995:47:1462-1469.
36. Sands H. Gorey-Fcret U. Cocuzza AJ, Hobbs FW. Chidester D. Trainor GL: Biodistribution and metabolism of internally 'H-labeled oligonucleotides. 1. Comparison of a phosphodiester and a phosphorolhioate. Mol Pharmacol 1994: 45:932-943.
37. Oberbauer R. Schreiner GF. Meyer TW: Renal uptake of an 18-mer phosphorolhioate oligonucleotide. Kidney lnt 1995;48:1226-1232.
38. Lokc SL. Stein CA, Zhang XH. Mori K, Na-kanishi M. Subasinghc C. Cohen JS, Neckers I.M: Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 1989:86:3474-3478.
39. Yakubov LA, Decva EA, Zarytova VF. Ivanova EM. Rvtc AS, Yurchenko LV. Vlassow VV: Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors? Proc Natl Acad Sci USA 1989;86:6454-6458.